Skip to main content
Top
Published in: Indian Journal of Gastroenterology 6/2011

01-12-2011 | Original Article

Association between gastric mucosal glutathione-S-transferase activity, glutathione-S-transferase gene polymorphisms and Helicobacter pylori infection in gastric cancer

Authors: Shweta Tripathi, Ujjala Ghoshal, Balraj Mittal, Dipti Chourasia, Sunil Kumar, Uday C. Ghoshal

Published in: Indian Journal of Gastroenterology | Issue 6/2011

Login to get access

Abstract

Aim

Helicobacter pylori infection, though common, leads to gastric cancer (GC) in less than 1% individuals, suggesting the role of host factors. We previously reported the role of glutathione–S–transferase (GST) polymorphisms, the gene encoding a carcinogen–detoxifying enzyme, in GC. This study was aimed to evaluate GST enzyme activity, GST polymorphism, glutathione (GSH) levels and H. pylori in patients with GC.

Methods

GST and GSH levels were estimated in gastric biopsies of 52 patients with GC, 37 functional dyspepsia (FD) and 39 peptic ulcer (PU), and correlated with H. pylori (ELISA) infection and GST polymorphisms. GST polymorphisms were separately analyzed in relationship to H. pylori in 82 GC, 72 FD, 53 PU and 89 healthy controls (HC).

Results

GST activity was lower in patients with GC in comparison to PU (p = 0.03), but GSH levels were comparable. GSTT1 null genotype (GSTT1*0) and simultaneous deletion of both GSTT1 and GSTM1 genes was associated with lower enzyme activity (p = 0.02 and 0.01, respectively). GST and GSH levels in H. pylori positive and negative patients with GC, FD and PU were comparable. Presence of H. pylori infection along with GSTT1*0 (p = 0.006) and GSTM1*0 (p = 0.05) was associated with lower enzyme activity. GSTT1*0 was associated with higher odds ratio (OR) of GC in presence of H. pylori (GC vs. HC: p = 0.02, OR 2.6 [95% CI = 1–6] vs. p = 0.7, 1.3 [0.4–5.0]; GC vs. PU: p = 0.04, OR 3 [95% CI = 1–9] vs. not applicable (OR could not be computed as frequency of GSTT1*0 in H. pylori negative patients with PU was zero)].

Conclusions

GC is associated with reduced GST activity. Odds ratio of GC associated with GSTT1*0 is enhanced in presence of H. pylori probably due to combined effect of both on enzyme activity.
Literature
1.
go back to reference Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on cancer epidemiology and prevention. Cancer Res. 1992;52:6735–40.PubMed Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on cancer epidemiology and prevention. Cancer Res. 1992;52:6735–40.PubMed
2.
go back to reference International Agency for Research on Cancer. In: Liver flukes and helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to human no. 61. Lycon: IARC; 1994. International Agency for Research on Cancer. In: Liver flukes and helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to human no. 61. Lycon: IARC; 1994.
3.
go back to reference Graham DY, Adam E, Reddy GT, et al. Seroepidemiology of helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci. 1991;36:1084–8.PubMedCrossRef Graham DY, Adam E, Reddy GT, et al. Seroepidemiology of helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci. 1991;36:1084–8.PubMedCrossRef
4.
go back to reference Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative helicobacter pylori infection. Gut. 1997;40:297–301.PubMed Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative helicobacter pylori infection. Gut. 1997;40:297–301.PubMed
5.
go back to reference Singh K, Ghoshal UC. Causal role of Helicobacter pylori in gastric cancer: an Asian enigma. World J Gastroenterol. 2006;12:1346–51.PubMed Singh K, Ghoshal UC. Causal role of Helicobacter pylori in gastric cancer: an Asian enigma. World J Gastroenterol. 2006;12:1346–51.PubMed
6.
go back to reference Ghoshal UC, Tiwari S, Dhingra S, et al. Frequency of Helicobacter pylori and CagA antibody in patients with gastric neoplasms and controls: the Indian enigma. Dig Dis Sci. 2008;53:1215–22.PubMedCrossRef Ghoshal UC, Tiwari S, Dhingra S, et al. Frequency of Helicobacter pylori and CagA antibody in patients with gastric neoplasms and controls: the Indian enigma. Dig Dis Sci. 2008;53:1215–22.PubMedCrossRef
7.
go back to reference Ghoshal UC, Tripathi S, Ghoshal U. The Indian enigma of frequent H. pylori infection but infrequent gastric cancer: is the magic key in Indian diet, host’s genetic make up, or friendly bug? Am J Gastroenterol. 2007;102:2113–4.PubMedCrossRef Ghoshal UC, Tripathi S, Ghoshal U. The Indian enigma of frequent H. pylori infection but infrequent gastric cancer: is the magic key in Indian diet, host’s genetic make up, or friendly bug? Am J Gastroenterol. 2007;102:2113–4.PubMedCrossRef
8.
go back to reference González CA, Sala N, Capellá G. Genetic susceptibility and gastric cancer risk. Int J Cancer. 2002;100:249–60.PubMedCrossRef González CA, Sala N, Capellá G. Genetic susceptibility and gastric cancer risk. Int J Cancer. 2002;100:249–60.PubMedCrossRef
9.
go back to reference Dong LM, Potter JD, White E, Ulrich CM, Cardon LR, Peters U. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA. 2008;299:2423–36.PubMedCrossRef Dong LM, Potter JD, White E, Ulrich CM, Cardon LR, Peters U. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA. 2008;299:2423–36.PubMedCrossRef
10.
go back to reference Gonzalez FJ. The role of carcinogen-metabolizing enzyme polymorphisms in cancer susceptibility. Reprod Toxicol. 1997;11:397–412.PubMedCrossRef Gonzalez FJ. The role of carcinogen-metabolizing enzyme polymorphisms in cancer susceptibility. Reprod Toxicol. 1997;11:397–412.PubMedCrossRef
11.
go back to reference Ketterer B. Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat Res. 1988;202:343–61.PubMedCrossRef Ketterer B. Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat Res. 1988;202:343–61.PubMedCrossRef
12.
go back to reference Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995;30:445–600.PubMedCrossRef Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995;30:445–600.PubMedCrossRef
13.
go back to reference Pemble S, Schroeder KR, Spencer SR, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J. 1994;300(Pt 1):271–6.PubMed Pemble S, Schroeder KR, Spencer SR, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J. 1994;300(Pt 1):271–6.PubMed
14.
go back to reference Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem. 1997;272:10004–12.PubMedCrossRef Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem. 1997;272:10004–12.PubMedCrossRef
15.
go back to reference Tripathi S, Ghoshal U, Ghoshal UC, et al. Gastric carcinogenesis: possible role of polymorphisms of GSTM1, GSTT1, and GSTP1 genes. Scand J Gastroenterol. 2008;43:431–9.PubMedCrossRef Tripathi S, Ghoshal U, Ghoshal UC, et al. Gastric carcinogenesis: possible role of polymorphisms of GSTM1, GSTT1, and GSTP1 genes. Scand J Gastroenterol. 2008;43:431–9.PubMedCrossRef
16.
go back to reference You WC, Hong JY, Zhang L, et al. Genetic polymorphisms of CYP2E1, GSTT1, GSTP1, GSTM1, ALDH2, and ODC and the risk of advanced precancerous gastric lesions in a Chinese population. Cancer Epidemiol Biomarkers Prev. 2005;14:451–8.PubMedCrossRef You WC, Hong JY, Zhang L, et al. Genetic polymorphisms of CYP2E1, GSTT1, GSTP1, GSTM1, ALDH2, and ODC and the risk of advanced precancerous gastric lesions in a Chinese population. Cancer Epidemiol Biomarkers Prev. 2005;14:451–8.PubMedCrossRef
17.
go back to reference Colombo J, Rossit AR, Caetano A, Borim AA, Wornrath D, Silva AE. GSTT1, GSTM1 and CYP2E1 genetic polymorphisms in gastric cancer and chronic gastritis in a Brazilian population. World J Gastroenterol. 2004;10:1240–5.PubMed Colombo J, Rossit AR, Caetano A, Borim AA, Wornrath D, Silva AE. GSTT1, GSTM1 and CYP2E1 genetic polymorphisms in gastric cancer and chronic gastritis in a Brazilian population. World J Gastroenterol. 2004;10:1240–5.PubMed
18.
go back to reference Martinez C, Martín F, Fernández JM, et al. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. Pharmacogenomics. 2006;7:711–8.PubMedCrossRef Martinez C, Martín F, Fernández JM, et al. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. Pharmacogenomics. 2006;7:711–8.PubMedCrossRef
19.
go back to reference Tamer LA, Ateş NA, Ateş C, et al. Glutathione S-transferase M1, T1 and P1 genetic polymorphisms, cigarette smoking and gastric cancer risk. Cell Biochem Funct. 2005;23:267–72.PubMedCrossRef Tamer LA, Ateş NA, Ateş C, et al. Glutathione S-transferase M1, T1 and P1 genetic polymorphisms, cigarette smoking and gastric cancer risk. Cell Biochem Funct. 2005;23:267–72.PubMedCrossRef
20.
go back to reference Verhulst ML, van Oijen AH, Roelofs HM, Peters WH, Jansen JB. Antral glutathione concentration and glutathione S-transferase activity in patients with and without Helicobacter pylori. Dig Dis Sci. 2000;45:629–32.PubMedCrossRef Verhulst ML, van Oijen AH, Roelofs HM, Peters WH, Jansen JB. Antral glutathione concentration and glutathione S-transferase activity in patients with and without Helicobacter pylori. Dig Dis Sci. 2000;45:629–32.PubMedCrossRef
21.
go back to reference Beil W, Obst B, Sewing KF, Wagner S. Helicobacter pylori reduces intracellular glutathione in gastric epithelial cells. Dig Dis Sci. 2000;45:1769–73.PubMedCrossRef Beil W, Obst B, Sewing KF, Wagner S. Helicobacter pylori reduces intracellular glutathione in gastric epithelial cells. Dig Dis Sci. 2000;45:1769–73.PubMedCrossRef
22.
go back to reference Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974;249:7130–9.PubMed Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974;249:7130–9.PubMed
23.
go back to reference Peters WH, Roelofs HM, Hectors MP, Nagengast FM, Jansen JB. Glutathione and glutathione S-transferases in Barrett’s epithelium. Br J Cancer. 1993;67:1413–7.PubMedCrossRef Peters WH, Roelofs HM, Hectors MP, Nagengast FM, Jansen JB. Glutathione and glutathione S-transferases in Barrett’s epithelium. Br J Cancer. 1993;67:1413–7.PubMedCrossRef
24.
go back to reference Oijen AH, Verhulst ML, Roelofs HM, Peters WH, de Boer WA, Jansen JB. Eradication of Helicobacter pylori restores glutathione S-transferase activity and glutathione levels in antral mucosa. Jpn J Cancer Res. 2001;92:1329–34.PubMedCrossRef Oijen AH, Verhulst ML, Roelofs HM, Peters WH, de Boer WA, Jansen JB. Eradication of Helicobacter pylori restores glutathione S-transferase activity and glutathione levels in antral mucosa. Jpn J Cancer Res. 2001;92:1329–34.PubMedCrossRef
25.
go back to reference Hoensch H, Morgenstern I, Petereit G, Siepmann M, Peters WH, Roelofs HM, et al. Influence of clinical factors, diet, and drugs on the human upper gastrointestinal glutathione system. Gut. 2002;50:235–40.PubMedCrossRef Hoensch H, Morgenstern I, Petereit G, Siepmann M, Peters WH, Roelofs HM, et al. Influence of clinical factors, diet, and drugs on the human upper gastrointestinal glutathione system. Gut. 2002;50:235–40.PubMedCrossRef
Metadata
Title
Association between gastric mucosal glutathione-S-transferase activity, glutathione-S-transferase gene polymorphisms and Helicobacter pylori infection in gastric cancer
Authors
Shweta Tripathi
Ujjala Ghoshal
Balraj Mittal
Dipti Chourasia
Sunil Kumar
Uday C. Ghoshal
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
Indian Journal of Gastroenterology / Issue 6/2011
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-011-0144-2

Other articles of this Issue 6/2011

Indian Journal of Gastroenterology 6/2011 Go to the issue

Gastroenterology Research

Gastroenterology Elsewhere

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.